34
Participants
Start Date
August 8, 2024
Primary Completion Date
August 1, 2028
Study Completion Date
August 1, 2029
RT (5x6 Gy) to the primary tumor and, if indicated, to lymph node and/or distant metastases.
Patients will receive RT (5x6 Gy) to the primary tumor and, if indicated, to lymph node and/or distant metastases. Enrolled patients will receive a fractionation scheme with increasing break length.
RECRUITING
Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting, Amsterdam
The Netherlands Cancer Institute
OTHER